NICOLETTE, CHARLES,DEBENEDETTE, MARK,HORVATINOVICH, JOSEPH
申请号:
CA3042683
公开号:
CA3042683A1
申请日:
2017.11.03
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
Antibodies are provided that alter the TLR4 signaling pathway to produce an immunosuppressive effect. The antibodies are useful for the treatment or prevention of an unwanted immune response in a subject, such as autoimmune disease, transplant rejection, and allergic reactions.